Ces radiol. 2016, 70(1):23-26 | DOI: 10.55095/CesRadiol2016/004

Metastatic melanoma detected by 99mTc-sestamibi SPECT/CT imaging during differentiated thyroid cancer follow-upOriginal article

Jiří Doležal, Marcela Koutníková, Eva Krčálová
Oddělení nukleární medicíny LF UK a FN, Hradec Králové

Aim: To present a rare case report of the metastatic melanoma detected by 99mTc-sestamibi SPECT/CT during differentiated thyroid cancer (DTC) follow-up imaging in a 43-year-old woman.

Method: The patient with positive history of DTC and malignant melanoma after treatment underwent follow-up 99mTc-sestamibi whole body scintigraphy. The additional chest SPECT/CT (single photon emission computed tomography/computed tomography) scan was done in order to improve the three-dimensional view of the axillary region with the increased activity of 99mTc-sestamibi. The multifunctional imaging scanner Infinia and processing system Xeleris (General Electic Healthcare) were used.

Results: The follow-up whole body scintigraphy and chest SPECT/CT revealed unexpected, incidental focal 99mTc-sestamibi uptake in the right axillary lymph node, which was subsequently excised and malignant melanoma metastasis was proven by histopathology.

Conclusion: SPECT/CT is an excellent imaging method facilitating exact spatial location of increased 99mTc-sestamibi in the chest region. The 99mTc-sestamibi SPECT/CT revealed right axillary malignant melanoma metastasis, improved patient management and allowed subsequent successful surgery treatment and changed the patient prognosis.

Keywords: thyroid cancer, melanoma, SPECT/CT, 99mTc-sestamibi
Grants and funding:

Podpořeno MZ ČR - RVO (FNHK, 00179906).

Accepted: February 15, 2016; Published: March 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Doležal J, Koutníková M, Krčálová E. Metastatic melanoma detected by 99mTc-sestamibi SPECT/CT imaging during differentiated thyroid cancer follow-up. Ces radiol. 2016;70(1):23-26. doi: 10.55095/CesRadiol2016/004.
Download citation

References

  1. Campenni A, Violi MA, Ruggeri RM, et al. Clinical usefulness of 99mTc-MIBI scintigraphy in the postsurgical evaluation of patiens with differentiated thyroid cancer. Nucl Med Commun 2010; 31(4): 274-279. Go to original source... Go to PubMed...
  2. Santini M, Firello A, Mansi L, et al. The role of technecium-99m hexakis-2-methoxyisobutyl isonitrile in the detection of neoplastic lung lesions. Eur J Cardiothorac Surg 2009; 35(2): 325-331. Go to original source... Go to PubMed...
  3. Ziessman HA, O'Malley JP, Thrall JH. Nuclear Medicine - The requisites in radiology. Philadelphia: Elsevier Mosby 2006; 275-279.
  4. Partap VA, Hickeson M, Josuu U. Metastatic melanoma detected by Tc-99m sestamibi dutiny routine cardiac imaging. Clin Nucl Med 1999; 24(12): 975-976. Go to original source... Go to PubMed...
  5. Jang Kim S, Won Seok J, Ju Kim I, Ki Kim Y. Tc-99m MIBI scintigraphy in a patient with primary and metastatic malignant melanoma. Clin Nucl Med 2002; 27(5): 351-353. Go to original source... Go to PubMed...
  6. Probst S, Lee J, Tu T, Berman R, Friedman K. Tc-99m sestamibi SPECT/CT with volumetric reconstruction for radioguided occult lesion localization and surgical excision of melanoma metastasis. Clin Nucl Med 2010; 35(3): 165-167. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.